IL84852A0 - Molecular cloning and expression of human il-3 - Google Patents

Molecular cloning and expression of human il-3

Info

Publication number
IL84852A0
IL84852A0 IL84852A IL8485287A IL84852A0 IL 84852 A0 IL84852 A0 IL 84852A0 IL 84852 A IL84852 A IL 84852A IL 8485287 A IL8485287 A IL 8485287A IL 84852 A0 IL84852 A0 IL 84852A0
Authority
IL
Israel
Prior art keywords
hil
expression
human
molecular cloning
produced
Prior art date
Application number
IL84852A
Other versions
IL84852A (en
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Publication of IL84852A0 publication Critical patent/IL84852A0/en
Publication of IL84852A publication Critical patent/IL84852A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A cDNA encoding human interleukin-3, also designated herein hIL-3 or hmulti-CSF, has been disposed in expression systems and caused to produce hIL-3 substantially free of impurities normally accompanying this protein as it is produced $i(inter alia) by peripheral blood lymphocytes in nature. The resulting hIL-3 can be produced in practical amounts and is useful in a variety of therapeutic and diagnostic protocols.
IL8485287A 1986-12-16 1987-12-16 Molecular cloning and expression of human IL-3 IL84852A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP86202285 1986-12-16
EP87201322 1987-07-13

Publications (2)

Publication Number Publication Date
IL84852A0 true IL84852A0 (en) 1988-06-30
IL84852A IL84852A (en) 1994-06-24

Family

ID=26103432

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8485287A IL84852A (en) 1986-12-16 1987-12-16 Molecular cloning and expression of human IL-3

Country Status (14)

Country Link
JP (2) JPH01502157A (en)
AT (1) ATE161882T1 (en)
AU (1) AU617095B2 (en)
CA (1) CA1341503C (en)
DE (1) DE3752158T2 (en)
ES (1) ES2113338T3 (en)
FI (1) FI102293B1 (en)
GR (1) GR3025857T3 (en)
IE (1) IE81129B1 (en)
IL (1) IL84852A (en)
NO (1) NO180544C (en)
NZ (1) NZ222939A (en)
PT (1) PT86381B (en)
WO (1) WO1988004691A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors
US6238889B1 (en) 1986-12-16 2001-05-29 Dsm N.V. Molecular cloning and expression of the Pro8 isoform of human IL-3
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".
US5304637A (en) * 1987-07-13 1994-04-19 Gist-Brocades N.V. Expression and purification of human interleukin-3 and muteins thereof
GB2210883B (en) * 1987-10-08 1992-01-02 British Bio Technology Synthetic interleukin-3 gene
US6384194B1 (en) 1987-12-16 2002-05-07 Dsm N.V. Expression and purification of human interleukin-3 and muteins thereof
EP0425536A4 (en) * 1988-07-20 1992-01-02 Immunex Corporation Nonglycosylated human interleukin-3 compositions
NZ232913A (en) * 1989-03-15 1992-08-26 Gist Brocades Nv Il-3 produced recombinantly and purified to homogeneity; vectors and pharmaceutical preparations
US5128450A (en) * 1989-06-30 1992-07-07 Urdal David L Nonglycosylated human interleukin-3 analog proteins
US5516512A (en) 1989-08-14 1996-05-14 Gist-Brocades, N.V. N- and C-terminal truncation and deletion mutants of human interleukin-3
ES2106017T3 (en) 1989-08-14 1997-11-01 Gist Brocades Nv INTERLEUKIN-3 HUMAN MUTANTS.
DE69125292T2 (en) * 1991-08-01 1997-09-25 Fond Nat Transfusion Sanguine Expression in non-tumorigenic human lymphoblast cell lines with an integrating vector
JPH08503706A (en) 1992-11-24 1996-04-23 ジー．ディー．サール アンド カンパニー Interleukin-3 (IL-3) multiple mutant polypeptide
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US5501962A (en) * 1993-06-21 1996-03-26 G. D. Searle & Co. Interleuken-3 (IL-3) human/murine hybrid polypeptides and recombinant production of the same
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO1999041382A2 (en) * 1998-02-17 1999-08-19 Hyseq, Inc. A novel interleukin-3 and uses thereof
US20090142294A1 (en) * 2005-01-25 2009-06-04 Apollo Life Sciences Limited Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes
JP2009532061A (en) * 2006-04-03 2009-09-10 ニユー・イングランド・バイオレイブス・インコーポレイテツド Expression, secretion and purification of recombinant bovine serum albumin (rBSA) and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695542A (en) * 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
AU570762B2 (en) * 1983-12-23 1988-03-24 Australian National University, The Cloning of cdna for il-3
GR871029B (en) * 1986-07-14 1987-11-02 Genetics Inst Novel osteoinductive factors

Also Published As

Publication number Publication date
DE3752158D1 (en) 1998-02-12
AU1057788A (en) 1988-07-15
DE3752158T2 (en) 1998-05-20
FI883688A0 (en) 1988-08-08
FI883688A (en) 1988-08-08
PT86381A (en) 1988-01-01
NO180544C (en) 1997-05-07
NO883614L (en) 1988-08-12
WO1988004691A1 (en) 1988-06-30
IE873409L (en) 1988-06-12
GR3025857T3 (en) 1998-04-30
ATE161882T1 (en) 1998-01-15
ES2113338T3 (en) 1998-05-01
NO180544B (en) 1997-01-27
PT86381B (en) 1990-11-20
JPH01502157A (en) 1989-08-03
NO883614D0 (en) 1988-08-12
FI102293B (en) 1998-11-13
NZ222939A (en) 1991-03-26
IL84852A (en) 1994-06-24
AU617095B2 (en) 1991-11-21
FI102293B1 (en) 1998-11-13
JPH1080286A (en) 1998-03-31
CA1341503C (en) 2006-04-04
IE81129B1 (en) 2000-03-22

Similar Documents

Publication Publication Date Title
IL84852A0 (en) Molecular cloning and expression of human il-3
ATE66614T1 (en) INSULIN PREPARATION FOR NON-PARENTERAL ADMINISTRATION.
IL112585A (en) N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them
EP0182634A3 (en) Antibodies and their production, diagnostic methods employing antibodies, and glycoproteins
EP0853121A3 (en) Human DNase
ATE152172T1 (en) PREPARATION OF A RECOMBINANT HUMAN INTERLEUKIN-1 INHIBITOR
DK193887A (en) PEPTID WITH BRONCHODIL ARTS AND HYPOTENSIVE ACTIVITY
EP0278696A3 (en) An arg-serpin human plasminogen activator inhibitor designated pai-2
HU901644D0 (en) Process for producing tissue-plasminogene activator
DE69033521T2 (en) USE OF ARGININE AS AN IMMUNE STIMULATOR
ES8302017A1 (en) Method of producing a factor-VIII(AHF)-high-concentrate
ATE85809T1 (en) PRODUCTION OF HUMAN VON WILLEBRAND FACTOR BY RECOMBINANT DNA.
EP0225020A3 (en) Peptides comprising, in sequence, units selected from the amino-acid residues 17 to 24 of vip
CA2154080A1 (en) Novel anticoagulant cofactor activity
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
ES8703488A1 (en) ZNS-active peptides acting on the cholinergetic system.
IT8521468A0 (en) PROCEDURE TO OBTAIN LEUKOCYTE INTERFERON ALPHA-2 FROM HUMAN.
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
JPS6456699A (en) Method for obtaining alpha 1-antitrypsin concentrate from human plasma and its utilization as drug
DE59704194D1 (en) USE OF MULTIPOTENT PARAMUNITY INDUCERS FROM ATTENUATED, NON-IMMUNOGENIC POX VIRUSES OR PARAPOCK VIRUSES FOR THE PRODUCTION OF MEDICINAL PRODUCTS
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
ES8204713A1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it.
FR2623628B1 (en) STANDARD SERUM, HUMAN IN NATURE, RECONSTITUTED FROM REJECTED FRACTIONS (NOT USED IN THERAPEUTICS), FRACTIONATION OF HUMAN PLASMA, HUMAN BLOOD, PLACENTAL OR RETROPLACENT BLOOD
FR2147150A1 (en) Crystalline leucoagglutinine prodn - from purified plant protein by chromatographic absorption of contaminants
JPS6423899A (en) Novel physiologically active polypeptide

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
HP Change in proprietorship
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees